Filter
6251
Filtered Results: 6251
Text search:
priority
diseases
Featured
Recommendations
607
New Publications
1700
Language
Document type
No document type
3319
Studies & Reports
1087
Guidelines
857
Strategic & Response Plan
352
Manuals
350
Fact sheets
105
Training Material
81
Situation Updates
60
Infographics
14
Resource Platforms
13
Brochures
10
Online Courses
2
Dashboards/Maps
1
Countries / Regions
Global
307
India
216
Kenya
189
Sierra Leone
142
Ethiopia
137
Liberia
122
Nepal
121
Uganda
120
Nigeria
117
South Africa
116
Africa
111
Western and Central Europe
110
Latin America and the Carribbean
100
Myanmar / Burma
90
Rwanda
89
Zambia
88
Bangladesh
87
Malawi
86
Congo, Democratic Republic of
78
Ghana
77
Tanzania
74
Syria
73
Namibia
57
Ukraine
56
Guinea
51
Senegal
49
Philippines
46
South–East Asia Region
45
Haiti
44
Eastern Europe
41
South Sudan
41
Mozambique
40
Asia
40
Lesotho
37
West and Central Africa
37
Zimbabwe
36
Cambodia
36
East and Southern Africa
34
Cameroon
32
Burkina Faso
31
Middle East and North Africa
31
Botswana
31
Indonesia
31
Yemen
29
Pakistan
25
Germany
24
Eastern Europe and Central Asia
24
Afghanistan
23
Russia
21
Côte d’Ivoire / Ivory Coast
19
Mali
19
Benin
17
Western Pacific Region
16
Sudan
16
Central African Republic
16
Brazil
15
Madagascar
15
Eswatini/ Swaziland
14
Venezuela
13
Somalia
13
Thailand
12
USA
12
Jordan
12
Moldova
12
Iraq
11
Niger
10
Burundi
10
Lebanon
10
Sri Lanka
9
Tajikistan
8
Togo
8
Albania
8
Laos
8
Georgia
8
Colombia
7
China
7
Vietnam
7
Chad
7
Timor Leste/ East Timor
6
Turkey
6
Peru
6
North America
6
Ecuador
6
Chile
5
United Kingdom
5
Papua New Guinea
5
Palestine
5
North Macedonia
4
Kazakhstan
4
Iran
4
Hungary
4
Saudi Arabia
4
Turkmenistan
4
France
4
Bolivia
4
Poland
4
Angola
4
Libya
4
Bhutan
4
Gambia
3
Kyrgyzstan
3
Armenia
3
Guinea-Bissau
3
Gabon
3
Mauritius
3
Tunisia
3
Belarus
3
Southern Africa
3
Egypt
3
Romania
3
El Salvador
2
Serbia
2
Canada
2
Fiji
2
Congo-Brazzaville
2
Uzbekistan
2
Morocco
2
Mongolia
2
Qatar
2
Bulgaria
2
Paraguay
2
Jamaica
2
Spain
2
Slovakia
2
Greece
2
Honduras
2
Guatemala
2
North Korea
1
Singapore
1
Estonia
1
Malaysia
1
Vanuatu
1
Mauritania
1
Dominican Republic
1
Cape Verde
1
Croatia
1
Lithuania
1
Ireland
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Algeria
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Guyana
1
Panama
1
Argentina
1
Nicaragua
1
Djibouti
1
Authors & Publishers
Publication Years
Category
Countries
2315
Clinical Guidelines
458
Key Resources
399
Public Health
378
Women & Child Health
296
Capacity Building
97
Pharmacy & Technologies
59
Annual Report MEDBOX
2
Toolboxes
COVID-19
611
HIV
500
Mental Health
364
TB
339
AMR
235
Rapid Response
220
Planetary Health
212
Ebola & Marburg
203
Conflict
166
Disability
163
Caregiver
161
NTDs
154
Global Health Education
120
NCDs
112
Malaria
102
Health Financing Toolbox
101
Pharmacy
98
Natural Hazards
97
Refugee
92
Cholera
51
Polio
46
Zika
40
Specific Hazards
23
Social Ethics
13
Typhoon
6
South Sudan
1
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
As of 21 May 2020, 4.8 million confirmed cases of Coronavirus disease 2019 (COVID-19) have been reported globally. In South America, COVID-19 was first detected on 26 February 2020, when Brazil confirmed a case in São Paulo.
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
The most frequent health problems of newly arrived refugees and migrants include accidental injuries, hypothermia, burns, gastrointestinal illnesses, cardiovascular events, pregnancy- and delivery-related complications, diabetes and hypertension. Female refugees and migrants frequently face specific...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Public Health is the science field dedicated to promoting health and well-being, and preventing disease within the human population to ultimately increase the quality of our livelihood and life span. Public Health does not focus on individual patients or diseases, but rather a given population and ...
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of disease (2016 data) (1). Air pollution alone causes about 7 million
deaths a year, placing it among the top global risks to health (2). Global envir...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of ...
This Strategic Response Plan for the measles emergency in the WHO European Region (SRP) articulates the overall status of measles resurgence in the WHO European Region and the priority actions needed to ensure an effective response to interrupt transmission, save lives and reverse the regional trend...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
